AI assistant
Catheter Precision, Inc. — Director's Dealing 2021
Jun 9, 2021
35479_dirs_2021-06-08_5908baa0-9061-4132-a17c-48af9328e6b5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Ra Medical Systems, Inc. (RMED)
CIK: 0001716621
Period of Report: 2021-06-04
Reporting Person: ENQUIST WILLIAM R (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-06-04 | Common Stock | A | 4000 | $0.00 | Acquired | 18766 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 5263 | Indirect |
Footnotes
F1: Reported shares represents a grant of restricted stock awards (the "RSAs") pursuant to Ra Medical Systems, Inc.'s 2018 Equity Incentive Plan. Each restricted stock award represents a contingent right to receive one share of Ra Medical Systems, Inc. common stock. The RSAs will vest on the earlier of (i) June 4, 2022, or (ii) the day prior to the date of the Stockholder's Annual Meeting next following June 4, 2021, subject to the
reporting person's continued service.
F2: Shares held of record by the Enquist Family Trust UAD 12/13/1990, for which the reporting person serves as trustee.